Skip to content

Evaluation of effect of the local infltration of bupivacain with or without dexamethasone on severity of acute pain in women undergoing cesarian section

Evaluation of effect of the local infltration of bupivacain with or without dexamethasone on severity of acute pain in women undergoing cesarian section

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220501054713N1
Enrollment
75
Registered
2022-05-22
Start date
2022-05-22
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain from cesarean section. Pelvic and perineal pain

Interventions

Intervention 1: Intervention group: Intervention group 1: The first procedure will inject 0.5 cc of marcaine 0.5% plus 10 cc of normal saline into the fascia and subcutaneous muscle. Intervention 2: I

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1- Pregnant women in the age range of 18 to 40 years 2- Women who are in ASA1 and ASA2 groups according to ASA (American Society of Anesthesiologists) in terms of physical condition.

Exclusion criteria

Exclusion criteria: Long surgery longer than two hours History of allergy to local anesthetics History of cesarean section more than twice History of drug abuse History of fibromyalgia or chronic nerve pain BMI above 35 Change the type of surgery.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale Score after cesarean section. Timepoint: VAS score after cesarean section at zero hours of recovery and one hour after surgery. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Dosage of the drug in the first 24 hours after cesarean section. Timepoint: the first 24 hours after cesarean section. Method of measurement: Total dose of drugs used per mg/dl.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHaleh Ayatollahi

Oroumia University of Medical Sciences

hayatollahi@yahoo.com+98 44 3223 4897

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026